ThinkableWhat is this?

Men's Health — Prostate Health

The Gland Nobody Talks About Until It's Too Late

The prostate is about the size of a walnut, sits in a place most men would rather not think about, and will quietly affect the health of nearly every man alive — yet most men know almost nothing about it until a doctor brings it up.

The Idea

The prostate is a small gland that sits just below the bladder, wrapping around the urethra like a donut. Its primary job is to produce fluid that protects and nourishes sperm. Unremarkable, until it isn't. The issue is that the prostate tends to grow as men age — a condition called benign prostatic hyperplasia (BPH) — and because it encircles the urethra, even modest enlargement can disrupt urinary flow in ways that range from mildly inconvenient to genuinely disruptive. But BPH is the benign story. Prostate cancer is the more serious one, and it is the most commonly diagnosed cancer in men in many countries. Here is what makes it genuinely tricky: prostate cancer is often slow-moving, and early-stage disease produces no symptoms whatsoever. This is both reassuring and dangerous — reassuring because it rarely kills quickly, dangerous because it can progress silently for years without detection. The standard screening tool is a blood test that measures PSA — prostate-specific antigen — a protein produced by prostate cells. Elevated PSA can signal cancer, but also inflammation, infection, or simply enlargement. This is why the science around PSA screening has been contested for decades: the test generates false positives that lead to unnecessary procedures, yet skipping it entirely misses cancers that could have been caught early. The research now leans toward informed, personalised screening conversations with a doctor, beginning around age 50 — or 40 to 45 for those with a family history or African heritage, both of which raise risk significantly.

In the World

In 2017, American actor and activist Ben Stiller revealed that he had been diagnosed with prostate cancer two years earlier, at age 48 — younger than most guidelines would have suggested he start screening. His PSA test had flagged an abnormality; a biopsy confirmed cancer. He underwent surgery, and by his own account, the cancer was caught early enough to treat successfully. What made his disclosure significant was not the celebrity angle but the specific argument he made: that a routine PSA test, taken during a regular check-up, had saved his life — and that without it, the cancer would almost certainly have progressed undetected. The reaction from the medical community was mixed, which itself tells you something important. Some doctors praised him for raising awareness. Others pointed out that his case illustrated the exact complexity of PSA screening — that not every detected cancer needs aggressive treatment, and that widespread screening can lead to overtreatment with serious side effects, including incontinence and erectile dysfunction. What Stiller's story captures is the live tension at the heart of prostate health: doing something early feels safer, but the intervention itself carries costs. The answer is not to avoid the conversation — it is to have a more sophisticated one. Which means knowing your family history, understanding your personal risk, and speaking to a doctor who will treat you as a participant in the decision, not just a recipient of it.

Why It Matters

Most men do not avoid thinking about prostate health because they are uninformed — they avoid it because the topic sits at an uncomfortable intersection of mortality, masculinity, and bodily vulnerability. There is something about the prostate specifically, its location, the nature of the tests involved, and what treatment can affect, that makes avoidance feel easier than engagement. But avoidance is never neutral. The men most likely to be harmed by prostate cancer are not those who screened and faced a difficult decision — they are those who never had the conversation at all. What shifts with this knowledge is not anxiety but agency. Knowing that risk is stratified by age, ancestry, and family history means you can stop treating prostate health as something that happens to men in their seventies and start treating it as something worth a straightforward conversation with your doctor in your forties. That conversation does not have to be alarming. It just has to happen. The gland nobody talks about is also the one most responsive to early attention.

A Question to Ponder

If you found out today that a close male relative had been diagnosed with prostate cancer, how would that change — if at all — what you do about your own health in the next six months?

Get a new one of these every morning.

Start learning with Thinkable
One topic like this, every day.Start free